Sensitivity and specificity of QRS duration to predict acute benefit in heart failure patients with ventricular resynchronization

被引：0
|
作者：
Butter, C
Kadhiresan, V
Vogt, J
Auricchio, A
Stellbrink, C
Fleck, E
Kramer, A
Spinelli, J
Ding, J
Liu, L
机构：
[1] German Heart Ctr, Dept Cardiol, Berlin, Germany
[2] Guidant Corp, CHF Res, St Paul, MN USA
[3] Ruhr Univ Bochum, Dept Cardiol, Bad Oeynhausen, Germany
[4] Univ Hosp, Dept Cardiol, Magdeburg, Germany
[5] Rhein Westfal TH Aachen, Med Einrichtungen, Dept Cardiol, Aachen, Germany
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1108
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Sensitivity and specificity of using QRS duration to predict chronic benefit in heart failure patients with cardiac resynchronization therapy
    Yu, Y
    Lamp, B
    Butter, C
    Auricchio, A
    Kloss, M
    Trautman, S
    Kirkels, H
    Stellbrink, C
    EUROPEAN HEART JOURNAL, 2002, 23 : 414 - 414
  • [2] Specificity and sensitivity of QRS duration to predict mortality in outpatients with heart failure
    Mansur, A. J.
    Schmuziger, T. S.
    Testa, C. B.
    Artes, R.
    Cuoco, M. A. R.
    Paula, R. S.
    Bertolzzo, N., Jr.
    Furuie, S. S.
    EUROPEAN HEART JOURNAL, 2008, 29 : 47 - 47
  • [3] Differences in the benefit of Cardiac Resynchronization Therapy (CRT) according to the QRS duration of patients with advanced heart failure
    Heiderfazel, S.
    Ewertsen, N. C.
    Kuck, K. H.
    Brachmann, J.
    Willems, S.
    Hoffmann, E.
    Horack, M.
    Senges, J.
    Andresen, D.
    EUROPEAN HEART JOURNAL, 2012, 33 : 996 - 996
  • [4] Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias
    Okafor, Osita
    Zegard, Abbasin
    van Dam, Peter
    Stegemann, Berthold
    Qiu, Tian
    Marshall, Howard
    Leyva, Francisco
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (21):
  • [5] Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure
    Mollema, Sjoerd A.
    Bleeker, Gabe B.
    van der Wall, Ernst E.
    Schalij, Martin J.
    Bax, Jeroen J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 1665 - 1670
  • [6] QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure
    Molhoek, SG
    Bax, JJ
    Boersma, E
    Van Erven, L
    Bootsma, M
    Steendijk, P
    Van Der Wall, EE
    Schalij, MJ
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (03): : 308 - 313
  • [7] Heart disease and QRS duration predict "hyperresponse" to cardiac resynchronization therapy
    Koutbi, L.
    Franceschi, F.
    Mancini, J.
    Bastard, E.
    Habib, G.
    Deharo, J. C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 307 - 307
  • [8] QRS duration and clinical outcomes in heart failure patients receiving cardiac resynchronization therapy
    Konstantinou, D.
    Guha, K.
    Cook, C.
    Sharma, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 585 - 585
  • [9] Cardiac resynchronization therapy: no benefit in heart failure with narrow QRS intervals
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (3): : 122 - 123
  • [10] Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure
    Yontar, Osman Can
    Yilmaz, Mehmet Birhan
    Yalta, Kenan
    Erdem, Alim
    Tandogan, Izzet
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 95 (06) : 738 - 742
12345